Home / Peptides / Tirzepatide

Tirzepatide Dosage Chart and Schedule

FDA-approved

Weekly GIP and GLP-1 agonist (Mounjaro, Zepbound). Label: 2.5 mg start, +2.5 mg every 4 weeks, max 15 mg.

Also called: Mounjaro, Zepbound, LY3298176

Regulatory status (US)

FDA-approved as Mounjaro (type 2 diabetes, 2022) and Zepbound (chronic weight management, 2023; obstructive sleep apnea, 2024). The FDA declared the tirzepatide shortage over in December 2024, which ended the temporary allowance for mass compounding.

What it is

A once-weekly injectable peptide that activates the GIP and GLP-1 receptors.

Label dose escalation (Mounjaro and Zepbound)

WeeksWeekly doseNote
1-42.5 mgStarting dose only, not a maintenance dose
5-85 mgPossible maintenance dose
9-127.5 mgIncrease in 2.5 mg steps after at least 4 weeks
13-1610 mgMaintenance dose
17-2012.5 mg
21+15 mgMaximum dose

From the Mounjaro and Zepbound prescribing information. A missed dose can be taken within 4 days (96 hours).

Tirzepatide reconstitution calculator

Enter your vial and your prescribed dose to see the units on a U-100 syringe. A units chart for every dose step is on the Tirzepatide reconstitution calculator page.

–
Concentration–
Per 1 unit (0.01 mL)–
Volume per dose–
Doses per vial–

What human studies show

Storage

Safety

Compare

Questions

Is Tirzepatide FDA-approved?
FDA-approved as Mounjaro (type 2 diabetes, 2022) and Zepbound (chronic weight management, 2023; obstructive sleep apnea, 2024). The FDA declared the tirzepatide shortage over in December 2024, which ended the temporary allowance for mass compounding.
What dose of Tirzepatide has been studied?
1-4: 2.5 mg: Starting dose only, not a maintenance dose; 5-8: 5 mg: Possible maintenance dose; 9-12: 7.5 mg: Increase in 2.5 mg steps after at least 4 weeks; 13-16: 10 mg: Maintenance dose; 17-20: 12.5 mg; 21+: 15 mg: Maximum dose. From the Mounjaro and Zepbound prescribing information. A missed dose can be taken within 4 days (96 hours).
How many units is my Tirzepatide dose?
Divide the mg in the vial by the mL of bacteriostatic water to get mg/mL, divide your dose in mg by that, and multiply by 100 for units on a U-100 syringe. The calculator on this page does it and draws the syringe.

Related

Semaglutide

Weekly GLP-1 agonist (Ozempic, Wegovy). Wegovy label: 0.25 mg start, up to 2.4 mg, or 7.2 mg (HD).

Orforglipron (Foundayo)

Daily GLP-1 pill from Lilly (Foundayo), approved April 2026. Not a peptide and never reconstituted.

Tesamorelin

GHRH analogue (Egrifta) approved for HIV-associated abdominal fat. Egrifta WR: 1.28 mg daily.

Elamipretide (SS-31)

Mitochondria-targeted peptide (Forzinity), approved 2025 only for Barth syndrome. Label: 40 mg daily.

Sources

  1. Mounjaro (tirzepatide) US prescribing information, Eli Lilly
  2. Zepbound (tirzepatide) US prescribing information, Eli Lilly
  3. FDA approves new medication for chronic weight management (Zepbound, Nov 2023)
  4. FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize
  5. FDA: Concerns with unapproved GLP-1 drugs used for weight loss
  6. FDA 510(k) K212499: BD insulin syringes for U-100 insulin

Last checked 2026-11-16. How we pick and check sources: methodology.